Vijay Chiruvolu
Director Técnico/Científico/I+D en TURNSTONE BIOLOGICS CORP. .
Fortuna: - $ al 30/04/2024
Perfil
Vijay Chiruvolu is currently the Chief Technology Officer at Turnstone Biologics Corp.
Prior to this, he was the Chief Technical Officer at Instil Bio, Inc. from 2020 to 2022.
He also held the position of Senior Vice President-Process Development at Kite Pharma, Inc. Dr. Chiruvolu holds an MBA from The Pennsylvania State University and a doctorate from The University of Nebraska-Lincoln.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 19/04/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Cargos activos de Vijay Chiruvolu
| Empresas | Cargo | Inicio |
|---|---|---|
| TURNSTONE BIOLOGICS CORP. | Director Técnico/Científico/I+D | 01/03/2023 |
Antiguos cargos conocidos de Vijay Chiruvolu.
| Empresas | Cargo | Fin |
|---|---|---|
| INSTIL BIO, INC. | Director Técnico/Científico/I+D | 02/09/2022 |
| KITE PHARMA INC | Corporate Officer/Principal | - |
Formación de Vijay Chiruvolu.
| The University of Nebraska-Lincoln | Doctorate Degree |
| The Pennsylvania State University | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| INSTIL BIO, INC. | Health Technology |
| TURNSTONE BIOLOGICS CORP. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Vijay Chiruvolu
